PGM5‐AS1 reduction resulted in upregulated E‐cadherin expression, downregulated expression of N‐cadherin and Vimentin (Fig. 5B,C), and attenuated migration and invasion in osteosarcoma cells (Fig. 5D,E). This evidence concerns the gene PGM5 and osteosarcoma.